Technical Articles
Recent Articles
How Atypical PKCζ Regulates Path...
Roles of Serine/Threonine Phosph...
Histone Crotonylation: Reshaping...
Anti-PD-1 Antibodies: Core Research Reagents for Nasopharyngeal Carcinoma Imm...
This article addresses core experimental limitations of EBV-associated nasopharyngeal carcinoma preclinical models, detailing PD-1/PD-L1 mediated T cell exhaustion and synergistic chemoimmunotherapy mechanisms for NPC research. ANT BIO supplies fully validated...
Anti-PD-1 Antibodies: Core Research Reagents for Nasopharyngeal Carcinoma Imm...
This article addresses core experimental limitations of EBV-associated nasopharyngeal carcinoma preclinical models, detailing PD-1/PD-L1 mediated T cell exhaustion and synergistic chemoimmunotherapy mechanisms for NPC research. ANT BIO supplies fully validated...
Read More
Human ErbB3 (HER3): From Accessory Co-Receptor to Central Signaling Hub and T...
Explore divergent translational trajectories of ERBB family receptors, focusing on catalytically impaired ErbB3 that drives EGFR/HER2 therapeutic resistance via NRG-dependent PI3K/AKT signaling. ANT BIO’s UA016071 HEK293-expressed human ErbB3-Fc chimera retains...
Human ErbB3 (HER3): From Accessory Co-Receptor to Central Signaling Hub and T...
Explore divergent translational trajectories of ERBB family receptors, focusing on catalytically impaired ErbB3 that drives EGFR/HER2 therapeutic resistance via NRG-dependent PI3K/AKT signaling. ANT BIO’s UA016071 HEK293-expressed human ErbB3-Fc chimera retains...
Read More
Innovative Directions in Therapeutic Antibody Engineering for Biopharma Precl...
Discover core drivers of next-gen antibody innovation for drug discovery, covering ADCs, multispecific antibodies, tumor-penetrating fragments and localized immunocytokines plus their distinct mechanistic strengths for solid tumor and immune preclinical...
Innovative Directions in Therapeutic Antibody Engineering for Biopharma Precl...
Discover core drivers of next-gen antibody innovation for drug discovery, covering ADCs, multispecific antibodies, tumor-penetrating fragments and localized immunocytokines plus their distinct mechanistic strengths for solid tumor and immune preclinical...
Read More
Enzyme-Linked Immunospot (ELISPOT): Single-Cell Resolution Assay for Function...
Learn ELISPOT core principles, single-cell cytokine detection advantages over bulk ELISA and compatible immune cell sample types for vaccine, CAR-T, infectious disease and autoimmunity research. This article covers standardized SFC...
Enzyme-Linked Immunospot (ELISPOT): Single-Cell Resolution Assay for Function...
Learn ELISPOT core principles, single-cell cytokine detection advantages over bulk ELISA and compatible immune cell sample types for vaccine, CAR-T, infectious disease and autoimmunity research. This article covers standardized SFC...
Read More
Multiplex Cytokine Detection for Non-Human Primate Th1/Th2 and Inflammatory I...
Non-human primates serve as translational bridging preclinical immunology models with conserved Th1/Th2 signaling yet distinct cytokine transcription profiles vs humans; human ELISA reagents cause biased NHP data. ANT BIO’s S0Q1002...
Multiplex Cytokine Detection for Non-Human Primate Th1/Th2 and Inflammatory I...
Non-human primates serve as translational bridging preclinical immunology models with conserved Th1/Th2 signaling yet distinct cytokine transcription profiles vs humans; human ELISA reagents cause biased NHP data. ANT BIO’s S0Q1002...
Read More
T Cell Exhaustion: Core Immunosuppressive Barriers in Chronic Infection and T...
This article defines T cell exhaustion, covering core phenotypes, metabolic drivers including CHSY1/HIF1A and S1PR3-mediated tumor microenvironment immune suppression, plus combinatorial intervention targeting metabolism, cell cycle and immune checkpoints. ANT...
T Cell Exhaustion: Core Immunosuppressive Barriers in Chronic Infection and T...
This article defines T cell exhaustion, covering core phenotypes, metabolic drivers including CHSY1/HIF1A and S1PR3-mediated tumor microenvironment immune suppression, plus combinatorial intervention targeting metabolism, cell cycle and immune checkpoints. ANT...
Read More